Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Piskol

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cancer Discovery|November 19, 2020
Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK PathwaysTrang H Pham, Thijs J Hagenbeek, Ho-June Lee, et al.
Nature Chemical Biology|May 6, 2018
Publisher Correction: A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cellsAaron H Nile, Felipe de Sousa E Melo, Susmith Mukund, et al.
Nature Chemical Biology|April 11, 2018
A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cellsAaron H Nile, Felipe de Sousa E Melo, Susmith Mukund, et al.
Blood Advances|August 1, 2022
Disruption of stem cell niche-confined R-spondin 3 expression leads to impaired hematopoiesisAntonina V Kurtova, Melanie Heinlein, Simon Haas, et al.
Cell Reports|February 9, 2022
CRAF dimerization with ARAF regulates KRAS-driven tumor growthAvinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Molecular Cancer Therapeutics|November 3, 2019
Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Immunity|February 13, 2020
Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMPYi Zhou, Mingjian Fei, Gu Zhang, et al.
Molecular Cancer Therapeutics|April 1, 2022
Novel Anti-LY6G6D/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Colorectal CancerPeiyin Wang, Liping L Sun, Robyn Clark, et al.
Science Advances|May 22, 2026
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicityYvonne T Kschonsak, Wei-Ching Liang, Joyce Chan, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer Discovery|November 19, 2020
Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK PathwaysTrang H Pham, Thijs J Hagenbeek, Ho-June Lee, et al.
Nature Chemical Biology|May 6, 2018
Publisher Correction: A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cellsAaron H Nile, Felipe de Sousa E Melo, Susmith Mukund, et al.
Nature Chemical Biology|April 11, 2018
A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cellsAaron H Nile, Felipe de Sousa E Melo, Susmith Mukund, et al.
Blood Advances|August 1, 2022
Disruption of stem cell niche-confined R-spondin 3 expression leads to impaired hematopoiesisAntonina V Kurtova, Melanie Heinlein, Simon Haas, et al.
Cell Reports|February 9, 2022
CRAF dimerization with ARAF regulates KRAS-driven tumor growthAvinashnarayan Venkatanarayan, Jason Liang, Ivana Yen, et al.
Molecular Cancer Therapeutics|December 29, 2017
An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Molecular Cancer Therapeutics|November 3, 2019
Correction: An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast CancerSunil Bhakta, Lisa M Crocker, Yvonne Chen, et al.
Immunity|February 13, 2020
Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMPYi Zhou, Mingjian Fei, Gu Zhang, et al.
Molecular Cancer Therapeutics|April 1, 2022
Novel Anti-LY6G6D/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Colorectal CancerPeiyin Wang, Liping L Sun, Robyn Clark, et al.
Science Advances|May 22, 2026
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicityYvonne T Kschonsak, Wei-Ching Liang, Joyce Chan, et al.
Pageof 5